IL60095A - Synergistic analgesic pharmaceutical compositions comprising nalbuphine and acetaminophen - Google Patents
Synergistic analgesic pharmaceutical compositions comprising nalbuphine and acetaminophenInfo
- Publication number
- IL60095A IL60095A IL60095A IL6009580A IL60095A IL 60095 A IL60095 A IL 60095A IL 60095 A IL60095 A IL 60095A IL 6009580 A IL6009580 A IL 6009580A IL 60095 A IL60095 A IL 60095A
- Authority
- IL
- Israel
- Prior art keywords
- nalbuphine
- acetaminophen
- pharmaceutical compositions
- analgesic pharmaceutical
- synergistic analgesic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/040,281 US4237140A (en) | 1979-05-18 | 1979-05-18 | Analgesic mixture of nalbuphine and acetaminophen |
Publications (2)
Publication Number | Publication Date |
---|---|
IL60095A0 IL60095A0 (en) | 1980-07-31 |
IL60095A true IL60095A (en) | 1982-12-31 |
Family
ID=21910135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL60095A IL60095A (en) | 1979-05-18 | 1980-05-16 | Synergistic analgesic pharmaceutical compositions comprising nalbuphine and acetaminophen |
Country Status (12)
Country | Link |
---|---|
US (1) | US4237140A (da) |
EP (1) | EP0019282B1 (da) |
JP (1) | JPS55154917A (da) |
AU (1) | AU529764B2 (da) |
CA (1) | CA1139671A (da) |
DE (1) | DE3061597D1 (da) |
HU (1) | HU178867B (da) |
IE (1) | IE49988B1 (da) |
IL (1) | IL60095A (da) |
NZ (1) | NZ193695A (da) |
PH (1) | PH15265A (da) |
ZA (1) | ZA802916B (da) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4322427A (en) * | 1981-04-16 | 1982-03-30 | Bristol-Myers Company | Analgetic compositions and methods of use |
US4366159A (en) * | 1981-09-08 | 1982-12-28 | Michael Richard Magruder | Nalbuphine-narcotic analgesic composition and method of producing analgesia |
US4404210A (en) * | 1982-06-30 | 1983-09-13 | E. I. Du Pont De Nemours And Company | Analgesic mixture of nalbuphine and ibuprofen |
US4404209A (en) * | 1982-06-30 | 1983-09-13 | E. I. Du Pont De Nemours And Company | Analgesic mixture of nalbuphine and sulindac |
US4404211A (en) * | 1982-06-30 | 1983-09-13 | E. I. Du Pont De Nemours And Company | Analgesic mixture of nalbuphine and flurbiprofen |
US4407805A (en) * | 1982-06-30 | 1983-10-04 | E. I. Du Pont De Nemours And Company | Analgesic mixture of nalbuphine and zomepirac |
US4407804A (en) * | 1982-06-30 | 1983-10-04 | E. I. Du Pont De Nemours And Company | Analgesic mixture of nalbuphine and indomethacin |
US4404208A (en) * | 1982-06-30 | 1983-09-13 | E. I. Du Pont De Nemours And Company | Analgesic mixture of nalbuphine and tiflamizole |
US4402962A (en) * | 1982-06-30 | 1983-09-06 | E. I. Du Pont De Nemours And Company | Analgesic mixture of nalbuphine and 4,5-bis(4-methoxyphenyl)-2-(trifluoromethylsulfonyl)-1H-imidazole |
AU565634B2 (en) * | 1982-06-30 | 1987-09-24 | E.I. Du Pont De Nemours And Company | Synergistic compositions of nalbuphine and non-narcotic analgesic compounds |
US4777174A (en) * | 1982-07-22 | 1988-10-11 | Analgesic Associates | Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same |
US4656177A (en) * | 1982-07-22 | 1987-04-07 | Analgesic Associates | Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same |
NL191432C (nl) * | 1982-07-22 | 1995-07-04 | Vicks Richardson | Farmaceutisch preparaat omvattende naproxen en een andere werkzame verbinding. |
US4600579A (en) * | 1983-06-07 | 1986-07-15 | Mallinckrodt, Inc. | N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same |
US4722928A (en) * | 1985-12-02 | 1988-02-02 | E. I. Du Pont De Nemours And Company | N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans having improved oral bioavailability, pharmaceutical compositions, and processes |
KR100243956B1 (ko) | 1991-09-06 | 2000-03-02 | 랄프 알. 팔로 | 트라마돌 물질 및 아세트아미노펜을 포함하는 통증 치료용 약제학적 조성물 |
US5558876A (en) * | 1995-03-29 | 1996-09-24 | Alcon Laboratories, Inc. | Topical ophthalmic acidic drug formulations |
US6348216B1 (en) * | 1996-06-10 | 2002-02-19 | Knoll Pharmaceutical Company | Ibuprofen and narcotic analgesic compositions |
US6361794B1 (en) | 1996-06-12 | 2002-03-26 | Basf Corporation | Method of making ibuprofen and narcotic analgesic composition |
PT1041987E (pt) | 1997-12-22 | 2006-07-31 | Euro Celtique Sa | Forma farmaceutica de dosagem oral, compreendendo uma combinacao de um agonista de opioide e naltrexona |
US6375957B1 (en) | 1997-12-22 | 2002-04-23 | Euro-Celtique, S.A. | Opioid agonist/opioid antagonist/acetaminophen combinations |
EP2092936B1 (en) | 2000-02-08 | 2013-03-20 | Euro-Celtique S.A. | Tamper-resistant oral opioid agonist formulations |
EP1387673B1 (en) | 2001-05-11 | 2010-12-29 | Endo Pharmaceuticals Inc. | Abuse-resistant controlled-release opioid dosage form |
ATE419039T1 (de) | 2001-07-18 | 2009-01-15 | Euro Celtique Sa | Pharmazeutische kombinationen von oxycodon und naloxon |
US20030044458A1 (en) | 2001-08-06 | 2003-03-06 | Curtis Wright | Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
WO2003013433A2 (en) | 2001-08-06 | 2003-02-20 | Euro-Celtique S.A. | Sequestered antagonist formulations |
RU2004106619A (ru) | 2001-08-06 | 2005-07-10 | Эро-Селтик С.А. (Lu) | Композиции опиоидного агониста, содержащие высвобождаемый и изолированный антагонист |
ES2733051T1 (es) | 2002-04-05 | 2019-11-27 | Euro Celtique Sa | Matriz para liberación sostenida, invariable e independiente de compuestos activos |
DK1551372T3 (da) | 2002-09-20 | 2018-07-23 | Alpharma Pharmaceuticals Llc | Sekvestreringsunderenhed og relaterede sammensætninger og fremgangsmåder |
US20040202717A1 (en) | 2003-04-08 | 2004-10-14 | Mehta Atul M. | Abuse-resistant oral dosage forms and method of use thereof |
TWI347201B (en) | 2003-04-21 | 2011-08-21 | Euro Celtique Sa | Pharmaceutical products,uses thereof and methods for preparing the same |
EP1604666A1 (en) | 2004-06-08 | 2005-12-14 | Euro-Celtique S.A. | Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD) |
EP1702558A1 (en) | 2005-02-28 | 2006-09-20 | Euro-Celtique S.A. | Method and device for the assessment of bowel function |
US8394812B2 (en) | 2005-08-24 | 2013-03-12 | Penwest Pharmaceuticals Co. | Sustained release formulations of nalbuphine |
CA2620224C (en) * | 2005-08-24 | 2015-11-24 | Penwest Pharmaceuticals Company | Sustained release formulations of nalbuphine |
KR20150029762A (ko) | 2006-06-19 | 2015-03-18 | 알파마 파머슈티컬스 엘엘씨 | 약제학적 조성물 |
US8623418B2 (en) | 2007-12-17 | 2014-01-07 | Alpharma Pharmaceuticals Llc | Pharmaceutical composition |
MY152279A (en) | 2009-03-10 | 2014-09-15 | Euro Celtique Sa | Immediate release pharmaceutical compositions comprising oxycodone and naloxone |
MY183489A (en) | 2013-07-23 | 2021-02-22 | Euro Celtique Sa | A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation |
RS63002B1 (sr) | 2013-12-24 | 2022-03-31 | Univ Virginia Commonwealth | Upotreba oksidovanog holesterol sulfata (ocs) za lečenje akutnog otkazivanja jetre |
US11260048B2 (en) | 2017-10-03 | 2022-03-01 | The Schepens Eye Research Institute, Inc. | Compounds and compositions for inhibiting retinal pigment epithelium degeneration and methods using the same |
JP7318987B2 (ja) * | 2018-09-03 | 2023-08-01 | ジェイコブ バイオテック リミテッド | セバコイルジナルブフィンとアセトアミノフェンの医薬品製剤及び疼痛を治療する方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL26896A (en) * | 1966-01-19 | 1970-11-30 | Endo Lab | 14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones |
US4029798A (en) * | 1975-06-02 | 1977-06-14 | Sumitomo Chemical Company, Limited | Analgetic composition |
JPS5946205B2 (ja) * | 1976-01-01 | 1984-11-10 | 科研製薬株式会社 | ベンゾイル誘導体を有効成分とする消炎鎮痛剤 |
-
1979
- 1979-05-18 US US06/040,281 patent/US4237140A/en not_active Expired - Lifetime
-
1980
- 1980-05-13 NZ NZ193695A patent/NZ193695A/en unknown
- 1980-05-13 AU AU58351/80A patent/AU529764B2/en not_active Ceased
- 1980-05-15 CA CA000352011A patent/CA1139671A/en not_active Expired
- 1980-05-15 EP EP80102696A patent/EP0019282B1/en not_active Expired
- 1980-05-15 DE DE8080102696T patent/DE3061597D1/de not_active Expired
- 1980-05-16 HU HU80801223A patent/HU178867B/hu not_active IP Right Cessation
- 1980-05-16 PH PH24035A patent/PH15265A/en unknown
- 1980-05-16 IL IL60095A patent/IL60095A/xx unknown
- 1980-05-16 ZA ZA00802916A patent/ZA802916B/xx unknown
- 1980-05-16 IE IE1019/80A patent/IE49988B1/en not_active IP Right Cessation
- 1980-05-17 JP JP6469980A patent/JPS55154917A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
AU5835180A (en) | 1980-11-20 |
ZA802916B (en) | 1981-12-30 |
US4237140A (en) | 1980-12-02 |
JPH0144684B2 (da) | 1989-09-29 |
AU529764B2 (en) | 1983-06-16 |
DE3061597D1 (en) | 1983-02-17 |
IE49988B1 (en) | 1986-01-22 |
IE801019L (en) | 1980-11-18 |
NZ193695A (en) | 1984-05-31 |
EP0019282A1 (en) | 1980-11-26 |
HU178867B (en) | 1982-07-28 |
PH15265A (en) | 1982-11-02 |
JPS55154917A (en) | 1980-12-02 |
IL60095A0 (en) | 1980-07-31 |
EP0019282B1 (en) | 1983-01-12 |
CA1139671A (en) | 1983-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL60095A (en) | Synergistic analgesic pharmaceutical compositions comprising nalbuphine and acetaminophen | |
GB2103591B (en) | Pharmaceutical compositions and process | |
DE3372705D1 (en) | Pharmaceutical composition and its use | |
NZ194432A (en) | Lipophilic muramyl-peptides and pharmaceutical compositions | |
PT76147A (en) | Process for the preparation of pyrazolooxazines pyrazolothiazines and pyrazoloquinolines with a lipoxygenase inhibiting effect and their use for the preparation of pharmaceutical compositions having a lipoxygenase inhibiting effect | |
NZ194961A (en) | Enkephalin analogues and pharmaceutical compositions | |
NZ193798A (en) | 3-thiovinyl-cephalosporin derivatives and pharmaceutical compositions | |
NZ194584A (en) | -lactam antibiotics and pharmaceutical compositions | |
NZ210105A (en) | Oxazolidine derivatives and pharmaceutical compositions | |
IL60550A (en) | Pharmaceutical compositions comprising aryl-pyrazolineamine derivatives and certain novel such compounds | |
PH16443A (en) | Substituted tetraazetricyclic compounds and their pharmaceutical compositions | |
DE2964696D1 (en) | N-(benzothienopyrazol)-amides and pharmaceutical compositions containing them | |
IL61700A (en) | Analgesic tetrapeptides,their preparation and pharmaceutical compositions comprising them | |
IL61703A (en) | Analgesic pentapeptides,their preparation and pharmaceutical compositions comprising them | |
IL61117A0 (en) | Acetoxymethyl-penem compounds and pharmaceutical compositions containing them | |
GB2047534B (en) | Analgesic and myotonolytic compositions | |
IL60376A (en) | 3-diphenylmethyleneazetidines and pharmaceutical compositions containing them | |
IL61701A (en) | Analgesic pentapeptides,their preparation and pharmaceutical compositions comprising them | |
GB2050833B (en) | Pharmaceutical compositions and process for the preparation thereof | |
IL69058A0 (en) | Synergistic pharmaceutical analgesic compositions | |
PH16220A (en) | Pyrro-lidine derivatives and pharmaceutical compositions thereof | |
IL59177A0 (en) | Spiro-quinolylhydantoins and pharmaceutical compositions containing them | |
NZ205732A (en) | Thiatriazine derivatives and pharmaceutical compositions | |
NZ203649A (en) | 2-beta-d-ribofuranosylselenazole-4-carboxamide derivatives and pharmaceutical compositions | |
IL60695A0 (en) | Hexahydro-trans-pyridoindole derivatives and pharmaceutical compositions containing them |